The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response
Emily F. Stamell(Albert Einstein College of Medicine), Isaac Brownell(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Jedd D. Wolchok(Cornell University), Sacha Gnjatic(Tisch Hospital), Nancy Y. Lee(Memorial Sloan Kettering Cancer Center)
International Journal of Radiation Oncology*Biology*Physics
January 9, 2013
Cited by 380
Related Papers
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Nivolumab plus Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2013|4.2k
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
|Nature Medicine|2012|3.7k
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
|New England Journal of Medicine|2019|3.7k